tiprankstipranks
Arcturus Therapeutics, CSL publish data on booster dose of ARCT-154
PremiumThe FlyArcturus Therapeutics, CSL publish data on booster dose of ARCT-154
7M ago
CSL upgraded to Conviction Buy from Buy at Goldman Sachs
PremiumThe Fly
CSL upgraded to Conviction Buy from Buy at Goldman Sachs
8M ago
CSL’s and Arcturus Therapeutics’ mRNA vaccine for COVID approved in Japan
PremiumThe Fly
CSL’s and Arcturus Therapeutics’ mRNA vaccine for COVID approved in Japan
8M ago
CSL Seqirus begins shipping portfolio of flu vaccines for 2023/24 U.S. season
PremiumThe FlyCSL Seqirus begins shipping portfolio of flu vaccines for 2023/24 U.S. season
1y ago
CSL says first patient receives FDA-approved HEMGENIX in U.S.
PremiumThe Fly
CSL says first patient receives FDA-approved HEMGENIX in U.S.
1y ago
CSL’s sparsentan did not achieve primary endpoint in glomerulosclerosis
PremiumThe Fly
CSL’s sparsentan did not achieve primary endpoint in glomerulosclerosis
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100